TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fiji Kava Limited ( (AU:CCO) ) just unveiled an update.
The Calmer Co. International Limited announced that all resolutions proposed at its Annual General Meeting were passed by the required majority, marking a successful outcome for the company. This development is likely to positively impact the company’s operations and reinforce its strategic positioning in the market for natural relaxation and sleep support products, benefiting stakeholders by potentially enhancing growth and market reach.
The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.
More about Fiji Kava Limited
The Calmer Co. International Limited is a fast-growing consumer packaged goods company specializing in kava and other natural products that promote relaxation, sleep support, and healthier alternatives to alcohol. Their products, which include drinking powders, kava shots, concentrates, and capsules, are sold under brands like Fiji Kava, Taki Mai, and Danodan Hempworks across the USA, Australia, New Zealand, China, and the Pacific Islands. The company leverages a global opportunity in the natural products market and distributes through e-commerce and blue-chip retail partners.
Technical Sentiment Signal: Sell
Current Market Cap: A$12.23M
Find detailed analytics on CCO stock on TipRanks’ Stock Analysis page.